NavaDerm Partners, a dermatology platform and portfolio company of BelHealth Investment Partners, announced the appointment of Leonard Bernstein, MD, as medical director of Laser & Skin Surgery of New York.

Board-certified dermatologist and Mohs Surgeon, Leonard J. Bernstein, MD, is a graduate of Northwestern University College of Arts and Science where he received a Bachelor of Arts degree in Chemistry. He received his Medical Degree at Northwestern University School of Medicine. He completed a dermatology residency at Northwestern Memorial Hospital / Northwestern University, where he was a chief resident, followed by a Mohs Micrographic Surgery and Laser fellowship at the Laser and Skin Surgery Center of New York ®. Dr. Bernstein is an Assistant Clinical Professor of Dermatology at New York Hospital/ Cornell Medical Center and holds an appointment in the Department of Plastic Surgery/Dermatology at Mount Sinai Hospital / New York Eye and Ear Infirmary. He is a Fellow of the American Academy of Dermatology, American Society of Lasers in Medicine and Surgery, the American College of Mohs Micrographic Surgery and Cutaneous Oncology, and the Manhattan Metropolitan Dermatologic Society.  He is the author of many research journal articles as well as textbook chapters on various laser and surgical techniques.  He has lectured over the past 30 years at national dermatologic meetings and seminars.

Health Technology Insights: Mānuka Health Unveils Pro Vitality Daily Restorative Collection

NavaDerm and LSSCNY Announce Change in Clinical Leadership

LSSCNY also announced the formation of its Clinical Advisory Board, which includes board certified dermatologists and renowned experts in medical and cosmetic dermatology and will provide strategic clinical guidance to LSSCNY’s medical director and NavaDerm’s board. The Clinical Advisory Board will consist of Robert Anolik, MD, Yoon-Soo (“Cindy”) Bae, MD, Roy Seidenberg, MD, and Ronald Shelton, MD. The Board will focus on maintaining LSSC’s leadership and reputation for skin health care through innovative treatments and lasers. The Board will also rejuvenate LSSC’s research capabilities and continue to work with leading device manufacturers and pharmaceutical companies.  

Cindy Bae, MD, a board-certified dermatologist and MOHS Surgeon, as well as a recipient of Castle Connolly Exceptional Women of the 2024 award, said, “I have had the pleasure of working closely with Dr. Bernstein for 11 years at LSSCNY and look forward to being part of the Clinical Advisory Board to further cement LSSCNY’s leadership position in medical and cosmetic dermatology.”

Health Technology Insights: Announcing Neuro Wellness Spa’s 11th Psychiatry and TMS Clinic

Inder Tallur, NavaDerm Chairman, stated “We are pleased with NavaDerm’s positioning in the fast-growing dermatology sector made possible by our renowned physicians and Mohs surgeons who provide patients with excellent clinical care. We wish Dr. Geronemus the very best and thank him for his hard work at LSSCNY over the years. We truly have some of the country’s top practicing dermatologists at LSSCNY and we will continue to provide them with the best support to provide quality care and service to their patients”

Dr. Bernstein stated “I am honored to become medical director of LSSCNY and continue to work alongside such esteemed and talented physicians. The newly created Board shows LSSCNY’s and NavaDerm’s commitment to remain at the forefront of innovation. I also look forward to bringing my experience as a physician to drive the best quality of care to our patients who come to us from all over the US and the world.”

Health Technology Insights: The Future of Breast Imaging Arrives in Dallas: Painless Mammogram Clinic Opens

To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com

Source – prnewswire